Question 1

Am I eligible for this trial based on my current treatment and health status?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer clinical trial (NCT06457919). Contact the study team or your healthcare provider for specific answers.

Question 2

How does tinengotinib compare to my current treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer clinical trial (NCT06457919). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer clinical trial (NCT06457919). Contact the study team or your healthcare provider for specific answers.

Question 4

How will my progress be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer clinical trial (NCT06457919). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects or my condition worsens?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer clinical trial (NCT06457919). Contact the study team or your healthcare provider for specific answers.

Question 6

Where will the trial take place, and how often will I need to visit?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer clinical trial (NCT06457919). Contact the study team or your healthcare provider for specific answers.

What this study is about